PODD · Company research
Insulet Corporation (PODD): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study | Dexcom's CONNECT trial results, published in The New England Journal of Medicine, demonstrate that its G7 continuous glucose monitoring system achieves a 1.6% A1C reduction in non-insulin-treated Type 2 diabetes patients, with 97% adherence at 26 weeks. The findings support broader CGM adoption and could expand market opportunities, though success depends on physician adoption and insurance coverage. The global CGM market is projected to grow from $13.4 billion in 2025 to $41.4 billion by 2033. | View source ↗ | Zacks Investment Research | Oct 20, 2026 | bullish | 0.75 | 1 |
| Platform Launch Might Change The Case For Investing In Insulet Stock (PODD) - Simply Wall Street | Platform Launch Might Change The Case For Investing In Insulet Stock (PODD) Simply Wall Street | View source ↗ | Simply Wall Street | Oct 17, 2026 | neutral | 0 | 0.6 |
| 2 of Wall Street’s Favorite Stocks to Target This Week and 1 We Ignore - Yahoo Finance | 2 of Wall Street’s Favorite Stocks to Target This Week and 1 We Ignore Yahoo Finance | View source ↗ | Yahoo Finance | Oct 16, 2026 | neutral | 0 | 0.6 |
| Here's Why Insulet (PODD) is a Strong Growth Stock | Zacks Premium offers investment research tools including Style Scores (Value, Growth, Momentum, and VGM) that complement the Zacks Rank system to help investors identify stocks with the highest probability of outperformance. The article highlights Insulet Corporation (PODD) as a stock to watch with a #3 Hold rank and strong growth prospects, recommending investors focus on stocks with #1 or #2 Zacks Rank combined with A or B Style Scores. | View source ↗ | Zacks Investment Research | Oct 16, 2026 | bullish | 1 | 1 |
| Insulet Corporation (PODD) Stock Forecasts - Yahoo Finance | Insulet Corporation (PODD) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| Insulet (PODD) Rolls Out Omnipod Discover Nationwide, Is The Stock Still Cheap? - Simply Wall Street | Insulet (PODD) Rolls Out Omnipod Discover Nationwide, Is The Stock Still Cheap? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 13, 2026 | neutral | 0 | 0.6 |
| A Look at Insulet Corp (PODD) After 3.4% Gain -- GF Value $398.3 - GuruFocus | A Look at Insulet Corp (PODD) After 3.4% Gain -- GF Value $398.3 GuruFocus | View source ↗ | GuruFocus | Oct 12, 2026 | neutral | 0 | 0.6 |
| Insulet Stock Gains as Traders Weigh Bullish Analyst Stance Against a Depressed Share Price - Quiver Quantitative | Insulet Stock Gains as Traders Weigh Bullish Analyst Stance Against a Depressed Share Price Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 12, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 12, 2026 | neutral | 0 | 0.6 |
| Findings link Omnipod Discover to a 3%+ rise in time blood sugar stayed in range for 32% of users. It's now nationwide. - Stock Titan | Findings link Omnipod Discover to a 3%+ rise in time blood sugar stayed in range for 32% of users. It's now nationwide. Stock Titan | View source ↗ | Stock Titan | Oct 12, 2026 | neutral | 0 | 0.6 |
| Insulet (NasdaqGS:PODD) Stock Forecast & Analyst Predictions - Simply Wall Street | Insulet (NasdaqGS:PODD) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 12, 2026 | neutral | 0 | 0.6 |
| Insulet Stock Price Forecast. Should You Buy PODD? - StockInvest.us | Insulet Stock Price Forecast. Should You Buy PODD? StockInvest.us | View source ↗ | StockInvest.us | Oct 9, 2026 | neutral | 0 | 0.6 |
| A tubeless insulin pump maker will report results before markets open Nov. 4. - Stock Titan | A tubeless insulin pump maker will report results before markets open Nov. 4. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| Insulet (PODD) Stock May Trade At A Discount To Fair Value - Yahoo Finance | Insulet (PODD) Stock May Trade At A Discount To Fair Value Yahoo Finance | View source ↗ | Yahoo Finance | Sep 25, 2026 | neutral | 0 | 0.6 |
| Insulet (PODD) Reworked Its Debt, Is The Stock Still Cheap? - Yahoo Finance | Insulet (PODD) Reworked Its Debt, Is The Stock Still Cheap? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 25, 2026 | neutral | 0 | 0.6 |
| Why Insulet (PODD) Stock Is Down Today - Quiver Quantitative | Why Insulet (PODD) Stock Is Down Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 8, 2026 | neutral | 0 | 0.6 |
| PODD Deadline Alert: Levi & Korsinsky Reminds Insulet Corporation (PODD) Investors of Securities Class Action Deadline on August 31, 2026 - PR Newswire | PODD Deadline Alert: Levi & Korsinsky Reminds Insulet Corporation (PODD) Investors of Securities Class Action Deadline on August 31, 2026 PR Newswire | View source ↗ | PR Newswire | Aug 19, 2026 | neutral | 0 | 0.6 |
| Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious - Yahoo Finance | Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious Yahoo Finance | View source ↗ | Yahoo Finance | Aug 6, 2026 | neutral | 0 | 0.6 |
| Why Insulet (PODD) Shares Are Sliding Today - StockStory | Why Insulet (PODD) Shares Are Sliding Today StockStory | View source ↗ | StockStory | Aug 5, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.